Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis

被引:134
|
作者
Eder, Lihi [1 ]
Thavaneswaran, Arane [1 ]
Chandran, Vinod [1 ]
Cook, Richard J. [2 ]
Gladman, Dafna D. [1 ]
机构
[1] Univ Toronto, Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Psoriat Arthrit Clin, Toronto, ON M5T 2S8, Canada
[2] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada
基金
加拿大健康研究院;
关键词
BODY-MASS INDEX; MARGINAL STRUCTURAL MODELS; WEIGHT-LOSS; RISK; SEVERITY; POPULATION; ADIPOKINES; PSA;
D O I
10.1136/annrheumdis-2013-204448
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To assess whether overweight and obese patients with psoriatic arthritis (PsA) are less likely to achieve sustained minimal disease activity (MDA) state compared to patients with normal weight. Methods A cohort of patients was assessed at the University of Toronto PsA clinic at 6-12-month intervals according to a standard protocol from 2003 to 2012. Patients were categorised into the following groups according to their body mass index (BMI): normal (< 25), overweight (25-30), and obese (> 30). Sustained MDA was defined as achieving low disease activity state in five or more of the following domains for at least 1 year: skin, enthesitis, tender and swollen joint counts, pain, patient global assessment and function. Proportional odds discrete time to event analysis was used to investigate the association between BMI category and the achievement of sustained MDA. Results Of the 557 patients included in the study, 36.2% were classified as overweight and 35.4% were obese. Overall, 66.1% of the patients achieved sustained MDA during the follow-up period. A dose-response association was found between obesity and the probability of achieving sustained MDA in the multivariate regression analysis. Patients in the higher BMI categories were less likely to achieve sustained MDA compared those in the lowest BMI category (overweight: OR 0.66 p= 0.003; obese: OR 0.53 p< 0.0001) after adjusting for potential confounding variables. Conclusions Overweight and obese patients with PsA are less likely to achieve sustained MDA compared to those of normal weight.
引用
收藏
页码:813 / 817
页数:5
相关论文
共 50 条
  • [31] Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity
    Baris Yilmazer
    Tayfun Sahin
    Berrin Öztaş Unlu
    Hale Maral Kir
    Ayse Cefle
    Rheumatology International, 2015, 35 : 1385 - 1392
  • [32] Anti-TNFα Discontinuation in Psoriatic Arthritis: Is It Possible After Achieving Minimal Disease Activity?
    Haddad, Amir
    Thavaneswaran, Arane
    Chandran, Vinod
    Gladman, Dafna D.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S580 - S581
  • [33] Value and Prediction of Minimal Disease Activity in Patients with Psoriatic Arthritis.
    Kavanaugh, Arthur
    Mease, Philip
    Coates, Laura C.
    McInnes, Iain B.
    Hojnik, Maja
    Dorr, Alex
    Zhang, Ying
    Guerette, Benoit
    Friedman, Alan
    Gladman, Dafna D.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S697 - S697
  • [34] ACHIEVING MINIMAL DISEASE ACTIVITY (MDA) CRITERIA DECREASES PROGRESSION OF JOINT DAMAGE IN PSORIATIC ARTHRITIS
    Coates, Laura C.
    Schentag, Catherine T.
    Lee, Ker-Ai
    Chandran, Vinod
    Cook, Richard J.
    Gladman, Dafna D.
    RHEUMATOLOGY, 2009, 48 : I51 - I52
  • [35] PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY OR REMISSION WITH APREMILAST TREATMENT AMONG DMARD-NAIVE SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS
    Mease, P. J.
    Kavanaugh, A.
    Ogdie, A.
    Wells, A. F.
    Bergman, M.
    Gladman, D. D.
    Behrens, F.
    Richter, S.
    Brunori, M.
    Teng, L.
    Guerette, B.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 767 - 768
  • [36] Probability of Achieving Low Disease Activity or Remission with Apremilast Treatment Among DMARD-Naive Subjects with Active Psoriatic Arthritis
    Mease, Philip
    Kavanaugh, Arthur
    Ogdie, Alexis
    Wells, Alvin
    Bergman, Martin
    Gladman, Dafna
    Behrens, Frank
    Richter, Sven
    Brunori, Michele
    Teng, Lichen
    Guerette, Benoit
    Smolen, Josef
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [37] BURDEN OF PSORIATIC ARTHRITIS IN DIFFERENT DEFINITIONS OF DISEASE ACTIVITY: COMPARING MINIMAL DISEASE ACTIVITY AND DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS
    Wervers, K.
    Vis, M.
    Tchetverikov, I.
    Gerards, A. H.
    Kok, M. R.
    Appels, C. W.
    van der Graaff, W. L.
    van Groenendael, J. H.
    Korswagen, L. A.
    Veris-Van Dieren, J. J.
    Hazes, J. M.
    Luime, J. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 363 - 363
  • [38] CERTOLIZUMAB PEGOL PROVIDES SUSTAINED REMISSION AND MINIMAL DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS OVER 4 YEARS' TREATMENT
    van der Heijde, D.
    Deodhar, A.
    FitzGerald, O.
    Fleischmann, R.
    Gladman, D.
    Gottlieb, A. B.
    Coates, L. C.
    Hoepken, B.
    Bauer, L.
    Peterson, L.
    Khraishi, M.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1027 - 1027
  • [39] MEASUREMENT OF DISEASE ACTIVITY IN PSORIATIC ARTHRITIS AND MINIMAL DISEASE ACTIVITY CRITERIA
    Coates, Laura
    RHEUMATOLOGY, 2013, 52 : 11 - 11
  • [40] Minimal Disease Activity among Psoriatic Arthritis Patients in Canada: Which Unmet Criteria are more Prevalent among Responders?
    Avina-Zubieta, Antonio
    Chow, Andrew
    Baer, Philip
    Kelsall, John
    Rahman, Proton
    Stewart, Jaqueline
    Haraoui, Boulos
    Zummer, Michel
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Nantel, Francois
    Maslova, Karina
    Tkaczyk, Cathy
    Osborne, Brendan
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1174 - 1175